News Daily News Young Survivors of Childhood Cancer Have Higher, Earlier Risk of CVD Events L.A. McKeown August 30, 2019
News Daily News FDA Approves Dalteparin Sodium as First Anticoagulant For Use in Pediatric VTE Patients Yael L. Maxwell May 16, 2019
News Daily News Updated AHA Scientific Statement Addresses CV Risk Reduction in High-Risk Youth Todd Neale March 05, 2019